Thomas Christian Kwee
#152,594
Most Influential Person Now
Researcher
Thomas Christian Kwee's AcademicInfluence.com Rankings
Thomas Christian Kweecomputer-science Degrees
Computer Science
#8135
World Rank
#8557
Historical Rank
Computational Linguistics
#1759
World Rank
#1777
Historical Rank
Machine Learning
#3239
World Rank
#3278
Historical Rank
Artificial Intelligence
#3546
World Rank
#3596
Historical Rank
Download Badge
Computer Science
Thomas Christian Kwee's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Thomas Christian Kwee Influential?
(Suggest an Edit or Addition)Thomas Christian Kwee's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology (2008) (403)
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer (2018) (380)
- Virchow-Robin spaces at MR imaging. (2007) (329)
- Imaging in local staging of gastric cancer: a systematic review. (2007) (288)
- Chest CT in COVID-19: What the Radiologist Needs to Know (2020) (267)
- Imaging in assessing lymph node status in gastric cancer (2009) (247)
- Imaging in staging of malignant lymphoma: a systematic review. (2008) (242)
- Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis (2008) (218)
- PET/MR imaging: technical aspects and potential clinical applications. (2013) (217)
- Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free‐breathing diffusion‐weighted MR imaging of the liver (2008) (215)
- Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation (2010) (199)
- Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. (2012) (173)
- Whole-body diffusion-weighted magnetic resonance imaging. (2009) (151)
- Predicting lymph node status in early gastric cancer (2008) (140)
- FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis (2008) (140)
- FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis (2014) (129)
- Diffusion coefficient measurement using a temperature‐controlled fluid for quality control in multicenter studies (2011) (126)
- Diffusion-weighted MR neurography of the brachial plexus: feasibility study. (2008) (122)
- ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. (2010) (119)
- FDG PET/CT in carcinoma of unknown primary (2009) (116)
- Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. (2011) (113)
- Whole-Body MRI, Including Diffusion-Weighted Imaging, for the Initial Staging of Malignant Lymphoma: Comparison to Computed Tomography (2009) (111)
- Additional value of gadoxetic acid‐DTPA‐enhanced hepatobiliary phase MR imaging in the diagnosis of early‐stage hepatocellular carcinoma: Comparison with dynamic triple‐phase multidetector CT imaging (2011) (109)
- Fundamentals of PET and PET/CT imaging (2011) (108)
- Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? (2014) (108)
- Influence of cardiac motion on diffusion-weighted magnetic resonance imaging of the liver (2009) (103)
- Complementary Roles of Whole-Body Diffusion-Weighted MRI and 18F-FDG PET: The State of the Art and Potential Applications (2010) (103)
- Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders (2011) (94)
- MR angiography in the follow-up of intracranial aneurysms treated with Guglielmi detachable coils: systematic review and meta-analysis (2007) (90)
- Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard (2014) (85)
- Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer (2009) (84)
- FDG PET for Diagnosing Infection in Hip and Knee Prostheses: Prospective Study in 221 Prostheses and Subgroup Comparison With Combined 111In-Labeled Leukocyte/99mTc-Sulfur Colloid Bone Marrow Imaging in 88 Prostheses (2014) (83)
- Whole-body diffusion-weighted imaging for staging malignant lymphoma in children (2010) (82)
- Chest CT Imaging Signature of Coronavirus Disease 2019 Infection (2020) (81)
- A new dimension of FDG-PET interpretation: assessment of tumor biology (2011) (81)
- Intravoxel water diffusion heterogeneity imaging of human high‐grade gliomas (2009) (79)
- Architectural configuration and microstructural properties of the sacral plexus: A diffusion tensor MRI and fiber tractography study (2012) (75)
- Rapid high resolution MR neurography with a diffusion-weighted pre-pulse. (2013) (73)
- Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high‐grade gliomas (2010) (72)
- Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis. (2016) (72)
- FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity (2014) (69)
- Bone marrow 18F‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B‐cell lymphoma (2014) (69)
- Orbital Lymphoproliferative Disorders (OLPDs): Value of MR Imaging for Differentiating Orbital Lymphoma from Benign OPLDs (2014) (66)
- Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma (2012) (63)
- Assessment of Small Bowel Motility in Patients With Chronic Intestinal Pseudo-Obstruction Using Cine-MRI (2013) (63)
- Prognostic value of complete remission status at end‐of‐treatment FDG‐PET in R‐CHOP‐treated diffuse large B‐cell lymphoma: systematic review and meta‐analysis (2015) (61)
- Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review (2012) (60)
- Patients’ views on the implementation of artificial intelligence in radiology: development and validation of a standardized questionnaire (2019) (58)
- Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. (2015) (57)
- The Accuracy of Endoscopic Ultrasonography in Differentiating Mucosal from Deeper Gastric Cancer (2008) (56)
- Prognostic value of interim FDG‐PET in Hodgkin lymphoma: systematic review and meta‐analysis (2015) (53)
- Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis (2016) (52)
- Whole‐body MRI, including diffusion‐weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study (2014) (52)
- Low b‐value diffusion‐weighted imaging: Emerging applications in the body (2012) (51)
- Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole‐body volumetric–metabolic FDG‐PET/CT metrics in diffuse large B‐cell lymphoma (2015) (50)
- Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension. (2019) (50)
- Diffusion-weighted MR neurography of the sacral plexus with unidirectional motion probing gradients (2009) (48)
- Systematic Review and Meta-Analysis on the Value of Chest CT in the Diagnosis of Coronavirus Disease (COVID-19): Sol Scientiae, Illustra Nos. (2020) (48)
- Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET (2013) (48)
- Diffusion-weighted MRI for evaluating perianal fistula activity: feasibility study. (2012) (43)
- Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma (2019) (43)
- Whole-body magnetic resonance neurography. (2009) (42)
- Gadoxetic acid disodium‐enhanced hepatocyte phase MRI: Can increasing the flip angle improve focal liver lesion detection? (2012) (42)
- Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma (2008) (40)
- ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphoma: feasibility study (2011) (40)
- SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions (2013) (38)
- DWI as an Imaging Biomarker for Bladder Cancer. (2017) (37)
- Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review (2015) (37)
- Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections (2018) (36)
- A Qualitative Study to Understand Patient Perspective on the Use of Artificial Intelligence in Radiology. (2019) (36)
- Whole‐body MRI‐DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study (2015) (35)
- Assessment of multiexponential diffusion features as MRI cancer therapy response metrics (2010) (35)
- Diffusion‐weighted MR imaging of the liver at 3.0 Tesla using TRacking Only Navigator echo (TRON): A feasibility study (2009) (34)
- Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer (2019) (34)
- Calcified or ossified benign soft tissue lesions that may simulate malignancy (2019) (33)
- Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy (2015) (33)
- Chest CT in COVID-19: What the Radiologist Needs to Know (2022) (33)
- Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance (2015) (31)
- Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy. (2017) (31)
- Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis (2021) (31)
- Modern imaging techniques for preoperative detection of distant metastases in gastric cancer. (2015) (30)
- Whole‐body magnetic resonance imaging, including diffusion‐weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma (2010) (30)
- Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis. (2016) (30)
- Whole-body MRI using a sliding table and repositioning surface coil approach (2009) (29)
- Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings (2014) (29)
- Role of FDG-PET/CT in children with fever of unknown origin (2020) (29)
- Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma. (2015) (29)
- CT-guided biopsy in suspected spondylodiscitis: microbiological yield, impact on antimicrobial treatment, and relationship with outcome (2018) (28)
- Should the ultrasound probe replace your stethoscope? A SICS-I sub-study comparing lung ultrasound and pulmonary auscultation in the critically ill (2020) (28)
- Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition. (2019) (28)
- Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis. (2018) (26)
- Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations (2017) (25)
- Chest CT Imaging Signature of COVID-19 Infection: In Pursuit of the Scientific Evidence (2020) (25)
- A brief overview of novel approaches to FDG PET imaging and quantification (2014) (25)
- Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation. (2021) (25)
- Subtraction of unidirectionally encoded images for suppression of heavily isotropic objects (SUSHI) for selective visualization of peripheral nerves (2010) (25)
- Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice (2015) (24)
- Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma. (2015) (24)
- Citation advantage for open access articles in European Radiology (2019) (24)
- T2‐weighted and diffusion‐weighted MRI for discriminating benign from malignant focal liver lesions: Diagnostic abilities of single versus combined interpretations (2012) (24)
- Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis (2021) (23)
- Ultrasound for diagnosing radiographically occult scaphoid fracture (2018) (23)
- False positives in PIRADS (V2) 3, 4, and 5 lesions: relationship with reader experience and zonal location (2019) (23)
- Cancer imaging: novel concepts in clinical magnetic resonance imaging (2010) (23)
- Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma? (2017) (22)
- Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? (2015) (21)
- Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries. (2015) (21)
- Diffusion-Weighted Magnetic Resonance Imaging of the Liver Using TRacking Only Navigator Echo: Feasibility Study (2010) (21)
- Bone marrow biopsy in diffuse large B-cell lymphoma: Useful or redundant test? (2015) (20)
- Whole‐body MRI for preventive health screening: A systematic review of the literature (2019) (20)
- Whole-body MRI vs. CT for staging lymphoma: patient experience. (2014) (20)
- Whole‐body MRI reveals high incidence of osteonecrosis in children treated for Hodgkin lymphoma (2017) (20)
- Overview of Positron Emission Tomography, Hybrid Positron Emission Tomography Instrumentation, and Positron Emission Tomography Quantification (2013) (20)
- Utility of computed diffusion‐weighted MRI for predicting aggressiveness of prostate cancer (2017) (19)
- FDG-PET/CT for Detecting an Infection Focus in Patients With Bloodstream Infection: Factors Affecting Diagnostic Yield (2019) (19)
- Culture yield of repeat percutaneous image-guided biopsy after a negative initial biopsy in suspected spondylodiscitis: a systematic review (2018) (19)
- Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. (2019) (19)
- Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation? (2015) (19)
- Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer. (2014) (19)
- 18F-FDG PET/CT in Autosomal Dominant Polycystic Kidney Disease Patients with Suspected Cyst Infection (2018) (19)
- Nononcological Applications of Positron Emission Tomography for Evaluation of the Thorax (2013) (18)
- Comparison of White Blood Cell Scintigraphy, FDG PET/CT and MRI in Suspected Diabetic Foot Infection: Results of a Large Retrospective Multicenter Study (2020) (18)
- Imaging of Bone Marrow Involvement in Lymphoma: State of the Art and Future Directions (2011) (18)
- A negative 18F-FDG-PET scan can never exclude residual disease. (2015) (17)
- FDG PET imaging for diagnosing prosthetic joint infection: discussing the facts, rectifying the unsupported claims and call for evidence-based and scientific approach (2013) (17)
- Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield (2019) (17)
- Workload of diagnostic radiologists in the foreseeable future based on recent scientific advances: growth expectations and role of artificial intelligence (2021) (17)
- Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma. (2015) (17)
- Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET (2011) (17)
- Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting (2011) (17)
- PET and PET/CT for unknown primary tumors. (2011) (17)
- Accuracy of whole-body MRI in the assessment of splenic involvement in lymphoma (2016) (17)
- Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? (2015) (16)
- An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma. (2017) (16)
- Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions (2020) (16)
- Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma (2017) (16)
- Ultrasonography in diagnosing clinically occult groin hernia: systematic review and meta-analysis (2018) (16)
- Beta-cell Imaging: Opportunities and Limitations (2011) (16)
- Magnetic resonance imaging of malignant lymphoma (2011) (16)
- Artificial Intelligence in Screening Mammography: A Population Survey of Women’s Preferences (2020) (16)
- Potential prognostic implications of whole‐body bone marrow MRI in diffuse large B‐cell lymphoma patients with a negative blind bone marrow biopsy (2014) (15)
- Diffusion-weighted whole-body imaging with background body signal suppression facilitates detection and evaluation of an anterior rib contusion. (2010) (14)
- Evolving Importance of Diffusion-Weighted Magnetic Resonance Imaging in Lymphoma. (2012) (14)
- Do People Favor Artificial Intelligence Over Physicians? A Survey Among the General Population and Their View on Artificial Intelligence in Medicine. (2021) (14)
- Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis (2018) (14)
- Semi-automatic software increases CT measurement accuracy but not response classification of colorectal liver metastases after chemotherapy. (2012) (14)
- Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma. (2014) (14)
- Tumefactive Virchow-Robin spaces. (2019) (13)
- Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT (2016) (13)
- Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study (2014) (13)
- Low b‐value diffusion‐weighted imaging for diagnosing strangulated small bowel obstruction: A feasibility study (2011) (13)
- Oncological Applications of Positron Emission Tomography for Evaluation of the Thorax (2013) (13)
- COVID-19 and chest CT: do not put the sensitivity value in the isolation room and look beyond the numbers (2020) (12)
- 18F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders (2020) (12)
- Outcome of Hodgkin Lymphoma Patients With a Posttreatment 18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography (FDG-PET)–Negative Residual Mass: Systematic Review and Meta-analysis (2015) (12)
- Imaging and clinical characteristics of children with multiple foci of microsusceptibility changes in the brain on susceptibility-weighted MRI (2010) (12)
- Diffusion-weighted MRI for detecting liver metastases: importance of the b-value (2010) (12)
- 18F-FDG PET for Diagnosing Infections in Prosthetic Joints. (2020) (12)
- The Crisis After the Crisis: The Time Is Now to Prepare Your Radiology Department (2020) (12)
- Fat suppression with Slice-Selection Gradient Reversal (SSGR) revisited; (2008) (12)
- Peristalsis gap sign at cine magnetic resonance imaging for diagnosing strangulated small bowel obstruction: feasibility study (2011) (11)
- Increased bone marrow FDG uptake at PET/CT is not a sufficient proof of bone marrow involvement in diffuse large B‐cell lymphoma (2015) (11)
- Carbon footprint of the RSNA annual meeting. (2020) (11)
- Artificial Intelligence in Screening Mammography: Is the General Population Ready? (2020) (11)
- Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. (2016) (11)
- Functional oncoimaging techniques with potential clinical applications. (2012) (11)
- Patient complaints in radiology: 9-year experience at a European tertiary care center (2019) (11)
- Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma. (2016) (11)
- Diffusion magnetic resonance imaging with gadofosveset trisodium as a negative contrast agent for lymph node metastases assessment (2011) (11)
- Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. (2021) (11)
- Influence of imperfect reference standard bias on the diagnostic performance of MRI in the detection of lymphomatous bone marrow involvement. (2013) (10)
- FDG-PET/CT for diagnosis of cyst infection in autosomal dominant polycystic kidney disease (2018) (10)
- Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease (2013) (10)
- Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model (2021) (10)
- Controversies on the prognostic value of interim FDG‐PET in advanced‐stage Hodgkin lymphoma (2016) (10)
- PET/CT Imaging for Personalized Management of Infectious Diseases (2021) (10)
- Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia (2020) (10)
- FDG-PET/CT in intensive care patients with bloodstream infection (2021) (9)
- Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG‐PET (2015) (9)
- Underestimated Role of 18F-FDG PET for HCC Evaluation and Promise of 18F-FDG PET/MR Imaging in This Setting (2013) (9)
- Age-related inflammatory changes in the spine as demonstrated by (18)F-FDG-PET:observation and insight into degenerative spinal changes. (2012) (9)
- The Added Value of [18F]FDG PET/CT in the Management of Invasive Fungal Infections (2021) (9)
- Pretransplant FDG‐PET in aggressive non‐Hodgkin lymphoma: systematic review and meta‐analysis (2017) (9)
- Can Full-Dose Contrast-Enhanced CT Be Omitted From an FDG-PET/CT Staging Examination in Newly Diagnosed FDG-Avid Lymphoma? (2014) (8)
- Single-center versus multi-center biparametric MRI radiomics approach for clinically significant peripheral zone prostate cancer (2021) (8)
- Diffusion weighted MR nerve sheath imaging (DW-NSI) using diffusion-sensitized driven-equiliblium (DSDE) (2011) (8)
- Clinical and Radiologic Predictors of Parastomal Hernia Development After End Colostomy. (2020) (8)
- Apparent diffusion coefficient measurement in a moving phantom simulating linear respiratory motion (2010) (8)
- Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study (2020) (8)
- Diffusion-weighted MRI for the detection of colorectal polyps: feasibility study. (2013) (8)
- Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial (2022) (8)
- Fabella Fractures after Total Knee Arthroplasty with Correction of Valgus Malalignment (2016) (8)
- MRI for staging lymphoma: Whole‐body or less? (2011) (7)
- Molecular imaging in lymphoma beyond 18F-FDG-PET: understanding the biology and its implications for diagnostics and therapy. (2020) (7)
- Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis (2018) (7)
- Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: A systematic review and meta‐analysis (2019) (7)
- FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging. (2019) (7)
- Whole-body MRI for Detecting Bone Marrow Metastases. (2010) (7)
- Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements (2019) (7)
- Both Interim and End-of-Treatment 18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Scans Have Low Value in Diffuse Large B-Cell Lymphoma. (2016) (7)
- Whole‐body MRI for staging Hodgkin lymphoma in a pregnant patient (2010) (7)
- Proportion of false-positive follow-up FDG-PET scans in lymphoma: Systematic review and meta-analysis. (2019) (7)
- Overestimated Value of Baseline Total Metabolic Tumor Volume at 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography in Follicular Lymphoma. (2017) (7)
- The New Integrated Nuclear Medicine and Radiology Residency Program in The Netherlands: Why Do Residents Choose to Subspecialize in Nuclear Medicine and Why Not? (2021) (7)
- Patient safety incidents in radiology: frequency and distribution of incident types (2020) (6)
- Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study (2016) (6)
- Radiofrequency ablation in the treatment of atypical cartilaginous tumours in the long bones: lessons learned from our experience (2018) (6)
- Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET (2017) (6)
- Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET/CT features (2021) (6)
- The Ongoing Misperception That Labeled Leukocyte Imaging Is Superior to 18F-FDG PET for Diagnosing Prosthetic Joint Infection (2017) (6)
- Successful conservative management of symptomatic bilateral dorsal patellar defects presenting with cartilage involvement and bone marrow edema: MRI findings (2016) (6)
- A New Working Paradigm for Radiologists in the Post-COVID-19 World (2021) (6)
- Surveillance MRI for the detection of locally recurrent Ewing sarcoma seems futile (2018) (6)
- Medical disciplinary jurisprudence in alleged malpractice in radiology: 10-year Dutch experience (2020) (6)
- Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study (2021) (6)
- Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients (2019) (6)
- Can whole-body MRI replace (18)F-fluorodeoxyglucose PET/CT? (2014) (6)
- Is MRI less accurate than FDG-PET/CT in diagnosing bone marrow involvement in lymphoma? (2011) (6)
- Predictive Value of Interim [18F]Fluorodeoxyglucose-Positron Emission Tomography in Advanced-Stage Hodgkin Lymphoma Is Not Well Established. (2017) (6)
- Anatomic dependency of phase shifts in the cerebral venous system of neonates at susceptibility‐weighted MRI (2011) (6)
- Funding of Radiology Research: Frequency and Association With Citation Rate. (2020) (6)
- Debate on the value of end-of-treatment FDG-PET response evaluation in follicular lymphoma (2017) (5)
- Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin’s lymphoma and primary mediastinal B-cell lymphoma (2018) (5)
- Should the nuclear medicine community continue to underestimate the potential of 18F-FDG-PET/CT with present generation scanners for the diagnosis of prosthetic joint infection? (2015) (5)
- Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma (2017) (5)
- Role of Structural Imaging in Lymphoma. (2012) (5)
- Characteristic Splenic Calcifications in Systemic Lupus Erythematosus. (2015) (5)
- Diagnostic performance of MRI and CT in diagnosing necrotizing soft tissue infection: a systematic review (2021) (5)
- Potential Clinical Applications of PET/Magnetic Resonance Imaging. (2013) (5)
- Abdominal adiposity and risk of pancreatic cancer. (2007) (5)
- Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome? (2016) (5)
- Peer review practices by medical imaging journals (2020) (5)
- Communication and empathy skills: Essential requisites for patient-centered radiology care. (2021) (5)
- FDG-PET/CT as a New Method for Diagnosis and Whole-Body Evaluation of Lemierre Syndrome. (2017) (5)
- Which patients are prone to undergo disproportionate recurrent CT imaging and should we worry? (2020) (5)
- Radiofrequency ablation of atypical cartilaginous tumors in long bones: a retrospective study (2019) (5)
- Effective performance of T(1)-weighted FLAIR Imaging with BLADE in pediatric brains. (2012) (5)
- Potential Causes of False-Negative Interpretations in 68Ga-PSMA PET/CT for the Detection of Local and Recurrent Prostate Cancer: An Underexposed Issue. (2019) (5)
- Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects (2016) (5)
- Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET–Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value? (2015) (5)
- Diagnostic performance of MRI in detecting locally recurrent soft tissue sarcoma: systematic review and meta-analysis (2022) (5)
- FDG-PET/CT Imaging of Infected Bones and Prosthetic Joints (2014) (5)
- MRI after Whoops procedure: diagnostic value for residual sarcoma and predictive value for an incomplete second resection (2021) (4)
- Carbon footprint of air travel to international radiology conferences: FOMO? (2020) (4)
- RAPID Trial Demonstrates Low Positive Predictive Value of Interim FDG-PET in Early-stage Hodgkin Lymphoma After Three Cycles of ABVD. (2016) (4)
- Interim Fluorodeoxyglucose Positron Emission Tomography-Adapted Therapy Is Not an Efficient Approach to Improving Outcome in Early-Stage Hodgkin Lymphoma. (2017) (4)
- Fact Sheet About Interim and End-of-Treatment 18F-FDG PET/CT in Lymphoma (2017) (4)
- Does end‐of‐treatment FDG‐PET provide any additional prognostic value to the pre‐treatment NCCN‐IPI score? (2017) (4)
- Gender diversity among editorial boards of radiology-related journals. (2021) (4)
- False‐negative FDG‐PET in histologically proven extensive large cell bone marrow involvement in diffuse large B‐cell lymphoma (2015) (4)
- Critical considerations on the utility of 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography/computed tomography for posttreatment restaging of the bone marrow in diffuse large B‐cell lymphoma (2014) (4)
- Dynamic susceptibility contrast MRI in advanced pancreatic cancer: semi‐automated analysis to predict response to chemotherapy (2010) (4)
- 18F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas. (2016) (4)
- Where Does Diffuse Large B-Cell Lymphoma Relapse? (2016) (4)
- Unread Second-Opinion Radiology Reports: A Potential Waste of Health Care Resources. (2020) (4)
- Benefit of brentuximab over bleomycin in first-line treatment of advanced-stage Hodgkin lymphoma has not been proven. (2018) (4)
- 18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: do we need additional tracers for clinical purposes? (2016) (4)
- Imaging of facet joint diseases. (2021) (4)
- Recommendations for additional imaging of abdominal imaging examinations: frequency, benefit, and cost (2019) (4)
- Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients? (2016) (4)
- Diffusion-weighted MRI of the liver for early tumor response assessment: Promising technique but evidence is still lacking (2010) (4)
- The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population (2020) (4)
- Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at? (2018) (4)
- Assessment of Bone Lesions with 18F-FDG PET Compared with 99mTc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management (2020) (4)
- A new complication registration system for errors in radiology: Initial 5-year experience in a tertiary care radiology department. (2020) (3)
- Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma (2015) (3)
- CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL. (2015) (3)
- Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Regard to Simontacchi et al. (2015) (3)
- A ruptured intracranial aneurysm with underlying cervicocranial fibromuscular dysplasia (2012) (3)
- Relationship between semiquantitative 18F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma (2019) (3)
- Interim FDG-PET in lymphoma, a questionable practice in hematology (2017) (3)
- Evidence-based reflection on the value of FDG-PET for interim and end-of-treatment response assessment in diffuse large B-cell lymphoma (2015) (3)
- Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [18F]FDG PET/CT (2021) (3)
- Canceled or aborted CT-guided interventions: 13-year clinical experience at a tertiary care center (2019) (3)
- Knee radiography in the diagnosis of skeletal dysplasias (2005) (3)
- Architectural con fi guration and microstructural properties of the sacral plexus : A diffusion tensor MRI and fi ber tractography study (2012) (3)
- Diagnostic errors in clinical FDG-PET/CT. (2020) (3)
- Letter to the Editor: No Evidence to Promote Interim FDG-PET Adapted Therapy in the NCCN Guidelines for Hodgkin Lymphoma. (2018) (3)
- The Need for Prudence When Using 18F-FDG PET as a Reference Standard for Lymphoma Detection (2017) (3)
- Improved Visualization of Middle Ear Cholesteatoma with Computed Diffusion-weighted Imaging (2018) (3)
- MR Neurography: Imaging of the Peripheral Nerves (2010) (3)
- Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. (2021) (3)
- No convincing evidence to support postinduction FDG-PET in follicular lymphoma (2016) (3)
- Early increase in single-kidney glomerular filtration rate after living kidney donation predicts long-term kidney function. (2022) (3)
- Overestimated value of FDG‐PET based bone marrow evaluation in lymphoma (2017) (3)
- Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma (2017) (3)
- JOURNAL CLUB: CT-Guided Bone Biopsies With Indeterminate Results in Pediatric Patients. (2018) (3)
- Interim FDG‐PET does not predict outcome in advanced‐stage Hodgkin lymphoma patients treated with BEACOPP (2018) (3)
- Point-of-care ultrasound (POCUS): An opportunity for radiologists to improve patient care? (2021) (3)
- Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements (2022) (3)
- The predictive value of interim FDG-PET in early-stage Hodgkin lymphoma is not well established. (2018) (3)
- Repeatability analysis of ADC histogram metrics of the uterus (2018) (3)
- Improving background suppression in diffusion-weighted imaging of the abdomen and pelvis using STIR with single-axis diffusion encoding. (2011) (3)
- Beware of False-Positive FDG PET/CT Interpretations for Presacral Recurrent Rectal Cancer. (2019) (3)
- Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma (2016) (2)
- Post‐ABVD biopsy results, and not post‐ABVD FDG‐PET results, predict outcome in early‐stage Hodgkin lymphoma (2019) (2)
- Quantitative Values from Synthetic MRI Correlate with Breast Cancer Subtypes (2021) (2)
- Reply: Interim PET in Hodgkin Lymphoma: Is It So Useless? (2017) (2)
- AI-assisted biparametric MRI surveillance of prostate cancer: feasibility study (2022) (2)
- Intravoxel water diffusion heterogeneity of human high-grade gliomas. (2009) (2)
- Recommendations in Clinical 18F-Fluoro-2-Deoxy-D-Glucose PET/CT Reports: Referring Physicians' Compliance and Diagnostic Yield. (2018) (2)
- Comparative Performance of Deep Learning and Radiologists for the Diagnosis and Localization of Clinically Significant Prostate Cancer at MRI: A Systematic Review (2022) (2)
- Interim FDG‐PET has no value in selecting patients who require treatment modification in both early‐ and advanced‐stage Hodgkin lymphoma (2018) (2)
- Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT (2017) (2)
- Hodgkin lymphoma: is there really a need for interim and end‐of‐treatment FDG‐PET evaluations? (2018) (2)
- Clinical and FDG-PET/CT Suspicion of Malignant Disease: Is Biopsy Confirmation Still Necessary? (2021) (2)
- A deep learning masked segmentation alternative to manual segmentation in biparametric MRI prostate cancer radiomics (2022) (2)
- The Apparent Diffusion Coefficient (ADC) as a Potential Marker of Inflammation Associated with Body Abscesses. (2017) (2)
- Effect of blind bone marrow biopsy on FDG‐PET/CT interpretation of the posterior iliac crest in diffuse large B‐cell lymphoma (2016) (2)
- Recommendations in Second Opinion Radiology Reports of Abdominal Imaging Examinations: Referring Clinicians' Compliance and Diagnostic Outcome. (2019) (2)
- Imaging of the Inner Ear at 7T: Initial Results (2010) (2)
- Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors? (2020) (2)
- Opinion on favoring labeled leukocyte imaging over 18 F-FDG-PET for diagnosing prosthetic joint infection : Rectifying ongoing misconceptions (2016) (2)
- Application of Advanced MR Imaging Techniques and the Evolving Role of PET/MR Imaging in Neuro-oncology. (2013) (2)
- Is FDG‐PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B‐cell lymphoma? (2016) (2)
- Patient safety in nuclear medicine: identification of key strategic areas for vigilance and improvement (2020) (2)
- The diagnostic significance of repeat ultrasound-guided biopsy of musculoskeletal soft-tissue lesions with initially inconclusive biopsy results. (2019) (2)
- Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination. (2022) (2)
- Negative PET: no guarantee of good prognosis in Hodgkin’s lymphoma (2015) (2)
- Assessing baseline bone marrow status in advanced-stage Hodgkin lymphoma: does it have any purpose? (2017) (2)
- Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma (2018) (2)
- Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: 18F-FDG PET, MR Imaging, or 18F-FDG PET/MR Imaging? (2013) (2)
- Funding of nuclear medicine research and association with citation impact (2021) (2)
- An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases (2021) (2)
- Maintenance of certification for radiologists: an overview of European countries (2020) (2)
- Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma. (2017) (2)
- Towards a benchmark of abdominal CT use during duty shifts: 15-year sample from the Netherlands (2020) (2)
- Value of detecting bone marrow involvement in Hodgkin lymphoma (2019) (2)
- Radiation Exposure and Lifetime Attributable Risk of Cancer Incidence and Mortality from Low- and Standard-Dose CT Chest: Implications for COVID-19 Pneumonia Subjects (2022) (2)
- Computed Tomography Observer Agreement in Staging Malignant Lymphoma (2016) (1)
- Scientific Fraud, Publication Bias, and Honorary Authorship in Nuclear Medicine (2022) (1)
- In Regard to Ceriani et al. (2017) (1)
- Corrigendum: Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET (vol 57, pg 534, 2017) (2018) (1)
- Scientific integrity and fraud in radiology research. (2022) (1)
- Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica (2022) (1)
- Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma (2017) (1)
- Research Output by Medical Doctors After PhD Graduation in Radiology: 17-Year Experience From the Netherlands. (2020) (1)
- Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma? (2015) (1)
- Shaking hands in a busy waiting room. The effects of the surveyor’s introduction and people present in the waiting room on the response rate (2021) (1)
- Incidental imaging findings referred to a specialized sarcoma center: Frequency, determinants, and downstream healthcare costs. (2022) (1)
- Doppler Ultrasound of Vascular Complications After Pediatric Liver Transplantation: Incidence, Time of Detection, and Positive Predictive Value (2022) (1)
- Prudence required when using 18 F-FDG PET as reference standard for lymphoma detection (2016) (1)
- Diffusion-Weighted MRI for Lymphoma Staging—Letter (2015) (1)
- Evolving Medical Imaging Techniques. (2013) (1)
- Frequency, Determinants, and Costs of Recommendations for Additional Imaging in Clinical 18F-FDG PET/CT Reports (2019) (1)
- Lesion detection by [Zr]Zr-DFO-girentuximab and [F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma (2020) (1)
- Chest CT in Patients with COVID-19: Toward a Better Appreciation of Study Results and Clinical Applicability (2020) (1)
- Whole-body DWI : reduction of scan time using direct coronal acquisition (2011) (1)
- PET Assessment of Brown Fat. (2011) (1)
- The Diabetic Foot. (2018) (1)
- Computer 3D modeling of radiofrequency ablation of atypical cartilaginous tumours in long bones using finite element methods and real patient anatomy (2022) (1)
- A 73% Price Reduction Does Not Indisputably Justify Routine Application of Brentuximab Vedotin as First-Line Treatment of Hodgkin Lymphoma. (2019) (1)
- End-of-treatment FDG-PET lacks usefulness in Hodgkin lymphoma (2016) (1)
- Did medical doctors who order abdominal CT scans during on-call hours truly become worse at clinical reasoning? Yes, they did (2022) (1)
- Radiologist-patient consultation of imaging findings after neck ultrasonography: An opportunity to practice value-based radiology. (2021) (1)
- Requests for radiologic imaging: Prevalence and determinants of inadequate quality according to RI-RADS. (2021) (1)
- A Pitfall for Diffusion-weighted MR Imaging When Assessing the Response to Neoadjuvant Chemotherapy in Ewing Sarcoma (2018) (1)
- Optimal radiological gallbladder lesion characterization by combining visual assessment with CT-based radiomics (2022) (1)
- Assessment of hepatic artery anatomy in pediatric liver transplant recipients: MR angiography versus CT angiography (2021) (1)
- Effects of control temperature, ablation time, and background tissue in radiofrequency ablation of osteoid osteoma: A computer modeling study (2021) (1)
- Radiologist-patient communication of musculoskeletal ultrasonography results: a choice between added value and costs. (2021) (1)
- Health Care Industry Payments to Editorial Board Members of Imaging-related Journals. (2022) (1)
- Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder (2021) (1)
- Combining Hepatic and Splenic CT Radiomic Features Improves Radiomic Analysis Performance for Liver Fibrosis Staging (2022) (1)
- Preventing unwanted blurring due to incomplete breath-hold at long breath-hold coronary MRA; Usefulness of new elliptical centric acquisition(CENTRA plus) (2012) (1)
- New MRI techniques for staging malignant lymphoma (2011) (1)
- Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment Escalation. (2019) (1)
- 18 F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders (2020) (1)
- Medical knowledge and clinical productivity: independently correlated metrics during radiology residency (2021) (1)
- Predictive value of a false-negative focused abdominal sonography for trauma (FAST) result in patients with confirmed traumatic abdominal injury (2020) (1)
- The integrated nuclear medicine and radiology residency program in the Netherlands: strengths and potential areas for improvement according to nuclear medicine physicians and radiologists (2021) (1)
- Diffusion-Weighted MRI for Lymphoma Restaging—Letter (2015) (1)
- The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients (2018) (1)
- Strikingly Heterogeneous Results Among Studies on Interim Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment in Advanced-Stage Hodgkin Lymphoma. (2018) (1)
- Dealing with a soft tissue lesion that is scheduled for CT-guided biopsy and that has decreased in size on preprocedural planning CT (2020) (0)
- Differentiation of hypointensity nodules on gadoxetic acid-enhanced hepatobiliary phase MRI using non-balanced spin-echo SSFP ( T 2 FFE ) (2013) (0)
- Hepatic artery and portal vein Doppler ultrasound reference values in children aged 0–17 years old (2022) (0)
- The Value of Deep Learning in Gallbladder Lesion Characterization (2023) (0)
- Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? (2019) (0)
- Starting as a Newly Graduated Radiologist: Survival Tips From Experience Experts. (2021) (0)
- Acknowledgement to referees (2008) (0)
- A new medical imaging postprocessing and interpretation concept to investigate the clinical relevance of incidentalomas: can we keep Pandora's box closed? (2023) (0)
- Mapping the cancer imaging research landscape: which cancers are more and which cancers are less frequently investigated? (2022) (0)
- On-call abdominal ultrasonography: the rate of negative examinations and incidentalomas in a European tertiary care center (2022) (0)
- Value-based radiology cannot thrive without reforms and research (2022) (0)
- Doppler-ultrasound reference values after pediatric liver transplantation: a consecutive cohort study. (2023) (0)
- Predictive gene-expression score for follicular lymphoma. (2018) (0)
- " T 1-enhanced " whole-brain black-blood RARE images using 3 D MSDE-TSE with anti driven equilibrium (2012) (0)
- University of Groningen Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections Ankrah, (2018) (0)
- Diagnostic performance of MRI in detecting residual soft tissue sarcoma after unplanned excision: systematic review and meta-analysis (2021) (0)
- Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. (2022) (0)
- Recommendations in Second Opinion Reports of Neurologic Head and Neck Imaging: Frequency, Referring Clinicians’ Compliance, and Diagnostic Yield (2021) (0)
- Retracted Publications in Medical Imaging Literature: an Analysis Using the Retraction Watch Database. (2022) (0)
- Reviewers January 2008—November 2008 (2009) (0)
- Point-of-care ultrasonography: Downstream utilization of and diagnostic (dis)agreements with additional cross-sectional imaging. (2022) (0)
- Whole-body MRI , including diffusion-weighted imaging , for staging lymphoma : comparison to CT in 101 patients (2011) (0)
- Suboptimal use of imaging in the new (National Comprehensive Cancer Network) International Prognostic Index for diffuse large B-cell lymphoma (2014) (0)
- Guest Editorial on PET of Benign Musculoskeletal Conditions. (2017) (0)
- University of Groningen Tumour necrosis as assessed with F-18-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements (2019) (0)
- Reply to "Additional Issues to Consider in Radiology Research". (2021) (0)
- Zr-DFO-girentuximab and [ 18 F ] FDG-PET / CT in patients with newly diagnosed metastatic renal cell carcinoma (2019) (0)
- Value of susceptibility-weighted imaging for diagnosing intracranial hemorrhage in neonates according to anatomic location (2009) (0)
- An Algorithm a Day Keeps the Doctor Away? A Survey Among the General Population and Their View on AI in Medicine (2021) (0)
- MP20-18 SEMI-AUTOMATIC SEGMENTATION ANALYSIS OF DIFFUSION-WEIGHTED MRI AS AN IMAGING BIOMARKER FOR HISTOLOGICAL GRADE OF BLADDER CANCER (2018) (0)
- Characterization of post-transplant lymphoproliferative disorder with semi-quantitative FDG-PET/CT (2019) (0)
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer (2018) (0)
- FDG PET in Diffuse Large B-Cell Lymphoma 18 Reply : Critical Views on the Prognostic Potential and Interpretation of Bone Marrow (2014) (0)
- University of Groningen Patient complaints in radiology (2019) (0)
- University of Groningen CT-guided biopsy in suspected spondylodiscitis (2018) (0)
- Time to Reconsider Routine Percutaneous Biopsy in Spondylodiscitis? (2021) (0)
- Macrodactyly with a complex glomuvenous malformation in congenital lipomatous overgrowth with vascular malformations, epidermal naevi and skeletal anomalies (CLOVES) syndrome (2018) (0)
- Unproven Clinical Value of Interim FDG-PET in Aggressive Non-Hodgkin Lymphoma. (2018) (0)
- Extra-Cranial Applications of Diffusion-Weighted MRI: Diffusion-weighted MRI of lymph nodes (2010) (0)
- [The issue of diversity in Dutch University Medical Centers: a role for professionals in leadership position]. (2022) (0)
- University of Groningen Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma Verhoeff, (2019) (0)
- Correction: Doppler Ultrasound of Vascular Complications After Pediatric Liver Transplantation: Incidence, Time of Detection, and Positive Predictive Value (2022) (0)
- Serious concerns on the inability of FDG-PET in excluding residual viable lymphoma (2018) (0)
- Editorial boards of imaging-related journals: selection process, terms, evaluation, and financial compensation. (2022) (0)
- Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective (2021) (0)
- Whole-body MRI, including diffusion-weighted imaging, compared to FDG-PET/CT for staging newly diagnosed lymphoma: Initial results (2011) (0)
- Integrity in cardiovascular imaging research. (2023) (0)
- Experiments on physical ablation of long bone using microwave ablation; defining optimal settings using ex- and in-vivo experiments (2023) (0)
- University of Groningen Role of FDG-PET/CT in children with fever of unknown origin Pijl, (2020) (0)
- Significant difference in dual time point PET findings: Hodgkin disease vs. non-Hodgkin lymphoma (2013) (0)
- Beyond the AJR: Beware of Publication Bias. (2022) (0)
- Pediatric Radiology Continuing Medical Education Activity (2010) (0)
- Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL—Letter (2016) (0)
- Standardized Definition of Progression-Free Survival in Diffuse Large B-Cell Lymphoma Is Urgently Needed. (2019) (0)
- Quality of Multicenter Studies Using MRI Radiomics for Diagnosing Clinically Significant Prostate Cancer: A Systematic Review (2022) (0)
- PET for Measuring Therapy Response After Radionuclide Therapy (2012) (0)
- Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment. (2020) (0)
- MRI for Detecting Bone Marrow Metastases (2010) (0)
- Publishing a research article in a major radiology journal: time investment from conception to proofreading after acceptance (2023) (0)
- Are Researchers Willing to Share Their Published Manuscript? (2018) (0)
- Assessing complete remission status in incurable follicular lymphomas, to what purpose? (2019) (0)
- 201. How can radiology help with diagnosis (2012) (0)
- Vessel-selective non-contrast enhanced time-resolved MR angiography using PULSER prepared 4 D T 1 TFE in intracranial arteries (2011) (0)
- PET and PET/CT Assessment of Gynecologic Malignancies: Beyond FDG. (2010) (0)
- Are Researchers Willing to Share Their Published Manuscript? (2018) (0)
- Spinal Teratoid/Rhabdoid Tumor: Use of Diffusion – Weighted Imaging for Diagnosis (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Christian Kwee?
Thomas Christian Kwee is affiliated with the following schools:
